Solventum
Precio: 79.22Empresa y modelo de negocio
Solventum operates in the healthcare sector, focusing on the development and commercialization of innovative medical solutions. Its core products include advanced therapeutic devices and diagnostic tools aimed at improving patient outcomes. The company generates revenue primarily through product sales and partnerships with healthcare providers and institutions. Solventum's business segments encompass research and development, manufacturing, and distribution of healthcare technologies.
Perfil de inversión
The investment profile of Solventum is more aligned with growth investors, given its focus on innovation and potential for revenue expansion. The company shows stable earnings growth and a moderate risk profile, appealing to those seeking capital appreciation. Its performance metrics suggest a favorable outlook for long-term investment strategies.
Métricas fundamentales
- EPS (TTM) — ganancias por acción de los últimos 12 meses, $
- 8.21 OK
- Ingresos QoQ — crecimiento trimestral de ingresos
- 0.5% ≈
- Sorpresa EPS
- 9.6% mejor de lo esperado
- Volatilidad 20d
- 2.1% estable
Impacto del pronóstico
agotadoSeguir en portafolio
Gráfico de precio
| Fecha | Antes | Después | Razón |
|---|---|---|---|
| 2026-06-10 00:49 | Mantener | Comprar | Strong momentum and positive EPS surprise indicate growth potential. |
| 2026-06-09 02:51 | Comprar | Mantener | Mixed performance and uncertain market conditions. |
| 2026-06-05 02:48 | Mantener | Comprar | Strong momentum and solid EPS growth support bullish outlook. |
| Fecha | Analista | Acción | Objetivo | Precio entonces |
|---|---|---|---|---|
| 2026-06-01 11:15 | Jefferies | Objetivo aumentado | — → 43 | 74.95 |
| 2026-05-15 11:13 | Wedbush | Actualizar | — → 94 | 74.42 |
| 2026-05-06 13:34 | UBS | Objetivo reducido | 82 → 78 | 71.355 |
Nada todavía